Roivant Sciences Stock Filter Stocks by Fundamentals
| ROIV Stock | USD 11.69 0.21 1.76% |
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Roivant | Shares Owned by Institutions |
Roivant Sciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Roivant Sciences from analyzing Roivant Sciences' financial statements. These drivers represent accounts that assess Roivant Sciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Roivant Sciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 235.1M | 367.6M | 1.5B | 4.1B | 2.1B | 1.3B |
Roivant Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Roivant Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Roivant Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Roivant Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Roivant Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Roivant Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Roivant Sciences' value.| Shares | Woodline Partners Lp | 2024-06-30 | 8 M | Geode Capital Management, Llc | 2024-06-30 | 6.3 M | Amvescap Plc. | 2024-06-30 | 5.9 M | Anchorage Advisors, Llc | 2024-06-30 | 4.8 M | Pointstate Capital Lp | 2024-06-30 | 4.5 M | Norges Bank | 2024-06-30 | 4.2 M | Goldman Sachs Group Inc | 2024-06-30 | 4.2 M | Adar1 Capital Management Llc | 2024-06-30 | 4.2 M | Adage Capital Partners Gp Llc | 2024-06-30 | 3.9 M | Sb Investment Advisers (uk) Ltd | 2024-06-30 | 71.4 M | Viking Global Investors Lp | 2024-06-30 | 69.2 M |
Roivant Fundamentals
| Return On Equity | 1.28 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | 29.92 % | ||||
| Operating Margin | (4.02) % | ||||
| Current Valuation | 3.34 B | ||||
| Shares Outstanding | 739.52 M | ||||
| Shares Owned By Insiders | 29.16 % | ||||
| Shares Owned By Institutions | 74.86 % | ||||
| Number Of Shares Shorted | 38.22 M | ||||
| Price To Book | 1.59 X | ||||
| Price To Sales | 54.61 X | ||||
| Revenue | 124.8 M | ||||
| Gross Profit | (477.06 M) | ||||
| EBITDA | (996.51 M) | ||||
| Net Income | 4.23 B | ||||
| Cash And Equivalents | 1.94 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 499.75 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 7.35 X | ||||
| Cash Flow From Operations | (765.27 M) | ||||
| Short Ratio | 9.42 X | ||||
| Earnings Per Share | 5.73 X | ||||
| Target Price | 17.06 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 8.65 B | ||||
| Total Asset | 7.22 B | ||||
| Retained Earnings | 576.17 M | ||||
| Working Capital | 6.47 B | ||||
| Net Asset | 7.22 B |
About Roivant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.